David Durantel PhD

David Durantel obtained his PhD in Molecular and Cellular Virology at the University of Montpellier in 1997. After three postdoctoral pieces of training respectively at Oxford Brookes University (with Pr Linda King and Robert Possee, UK), the University of Oxford (with Pr R.aymond Dwek and Dr. Nicole Zitzmann, UK), and INSERM (National Institute for Health and Medical Research; with Pr Fabien Zoulim), he has have obtained a tenured position in 2005 at INSERM, then his Habilitation to direct research in 2008 from the University of Lyon (UCBL1), and was finally promoted Director of Research in 2016. During all these years, he worked on numerous research projects related to drug discovery (on both Direct Acting (DAA) and Host-Targeting Agents (HTA)) in the viral hepatitis field. As a reward for his dedication to the antiviral research field, he received the 2021 William Prusoff Award from the International Society for Antiviral Research (ISAR) and currently serves the society as chairman of the Finance Committee.